cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer ; volume:5 ; number:1 ; day:19 ; month:3 ; year:2016 ; pages:1-10 ; date:12.2016
SpringerPlus ; 5, Heft 1 (19.3.2016), 1-10, 12.2016
- Creator
-
Cozzo, Alyssa J.
- Contributor
-
Sundaram, Sneha
Zattra, Ottavia
Qin, Yuanyuan
Freemerman, Alex J.
Essaid, Luma
Darr, David B.
Montgomery, Stephanie A.
McNaughton, Kirk K.
Ezzell, J. Ashley
Galanko, Joseph A.
Troester, Melissa A.
Makowski, Liza
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-1920-3
- URN
-
urn:nbn:de:1111-2016032516760
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cozzo, Alyssa J.
- Sundaram, Sneha
- Zattra, Ottavia
- Qin, Yuanyuan
- Freemerman, Alex J.
- Essaid, Luma
- Darr, David B.
- Montgomery, Stephanie A.
- McNaughton, Kirk K.
- Ezzell, J. Ashley
- Galanko, Joseph A.
- Troester, Melissa A.
- Makowski, Liza
- SpringerLink (Online service)
Other Objects (12)
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Weight loss reduces basal-like breast cancer through kinome reprogramming
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
ME1 promotes basal-like breast cancer progression and associates with poor prognosis
Increased gene expression variability in BRCA1-associated and basal-like breast tumours
MFAP5 promotes basal-like breast cancer progression by activating the EMT program
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Weight loss reduces basal-like breast cancer through kinome reprogramming
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
ME1 promotes basal-like breast cancer progression and associates with poor prognosis
Increased gene expression variability in BRCA1-associated and basal-like breast tumours
MFAP5 promotes basal-like breast cancer progression by activating the EMT program
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Weight loss reduces basal-like breast cancer through kinome reprogramming
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
ME1 promotes basal-like breast cancer progression and associates with poor prognosis
Increased gene expression variability in BRCA1-associated and basal-like breast tumours